14.16

8.23% -1.27

Jade Biosciences Inc (JBIO)

Overview News Price History Discussions Forecast

Jade Biosciences Inc stock is traded at $14.16, with a volume of 237.24K. It is down -8.23% in the last 24 hours and up +21.86% over the past month. Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

Previous Close:

$15.43

Open:

$15.43

24h Volume:

237.24K

Relative Volume:

0.87

Market Cap:

$698.29M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-13.92%

1M Performance:

+21.86%

6M Performance:

+31.11%

1Y Performance:

+0.00%

1-Day Range:

$13.88

$15.93

1-Week Range:

$13.88

$16.81

52-Week Range:

$6.565

$17.71

Jade Biosciences Inc Stock (JBIO) Company Profile

Name

Jade Biosciences Inc

Sector

Healthcare (1131)

Industry

Biotechnology (631)

Phone

(781) 312-3013

Address

221 CRESCENT ST., WALTHAM

Employee

Twitter

Next Earnings Date

2025-05-19

Latest SEC Filings

JBIO's Discussions on Twitter

Compare JBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JBIO Jade Biosciences Inc	14.16	760.92M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	452.13	115.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.31	81.12B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.17	52.54B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	839.99	51.78B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.12	37.12B	447.02M	-1.18B	-906.14M	-6.1812

Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-09-25	Initiated	BTIG Research	Buy
Jul-14-25	Initiated	Jefferies	Buy
Jun-16-25	Upgrade	Guggenheim	Neutral → Buy
May-07-25	Initiated	Wedbush	Outperform
May-05-25	Initiated	Stifel	Buy
May-02-25	Initiated	TD Cowen	Buy
Jun-18-24	Downgrade	Evercore ISI	Outperform → In-line
Jun-18-24	Downgrade	TD Cowen	Buy → Hold
Jun-18-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-24	Downgrade	BTIG Research	Buy → Neutral
Jun-17-24	Downgrade	Guggenheim	Buy → Neutral
Jun-17-24	Downgrade	Wedbush	Outperform → Neutral
Mar-25-24	Resumed	Jefferies	Buy
Dec-08-23	Initiated	Wells Fargo	Equal Weight
Mar-01-23	Initiated	Guggenheim	Buy
Dec-06-22	Upgrade	BTIG Research	Neutral → Buy
Sep-19-22	Resumed	Wedbush	Outperform
Aug-16-22	Downgrade	BTIG Research	Buy → Neutral
Feb-11-22	Initiated	BTIG Research	Buy
Jul-26-21	Initiated	Cowen	Outperform
Jul-26-21	Initiated	Evercore ISI	Outperform
Jul-26-21	Initiated	Jefferies	Buy
Jul-26-21	Initiated	Wedbush	Outperform

View All

Jade Biosciences Inc Stock (JBIO) Latest News

Dec 30, 2025

Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7%Here's Why - MarketBeat

Dec 30, 2025

Dec 26, 2025

Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN

Dec 26, 2025

Dec 24, 2025

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5%Here's What Happened - MarketBeat

Dec 24, 2025

Dec 23, 2025

Wedbush Adjusts Price Target on Jade Biosciences to $24 From $19, Maintains Outperform Rating - marketscreener.com

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 23, 2025

Volume Report: Why Jade Biosciences Inc stock is popular among millennials2025 Technical Patterns & Daily Growth Stock Tips - moha.gov.vn

Dec 23, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Dec 23, 2025

Dec 22, 2025

Jade Biosciences files for offering of 3.2 million shares of common stock by selling stockholderSEC filing - marketscreener.com

Dec 22, 2025

Jade Biosciences (NASDAQ:JBIO) Trading Down 4.5%Here's What Happened - MarketBeat

Dec 22, 2025

What analysts say about Jade Biosciences Inc stockStock Liquidity Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Dec 22, 2025

Dec 20, 2025

Is Jade Biosciences Inc. stock supported by strong cash flowsGap Down & Real-Time Chart Pattern Alerts - Улправда

Dec 20, 2025

Why Jade Biosciences Inc. stock is a value investor pickPortfolio Return Report & Accurate Intraday Trading Signals - Улправда

Dec 20, 2025

Dec 19, 2025

Is Jade Biosciences Inc. stock resilient to inflationWeekly Trade Recap & Capital Protection Trading Alerts - Улправда

Dec 19, 2025

Will Jade Biosciences Inc. stock rally after Fed decisionsJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда

Dec 19, 2025

Form 424B3 Jade Biosciences, Inc. - StreetInsider

Dec 19, 2025

Published on: 2025-12-19 20:08:24 - Улправда

Dec 19, 2025

Is Jade Biosciences Inc. stock a safe investment in uncertain marketsGap Up & AI Forecasted Entry/Exit Points - Улправда

Dec 19, 2025

How risky is Jade Biosciences Inc. stock nowMarket Trend Report & Daily Momentum Trading Reports - DonanımHaber

Dec 19, 2025

Will Jade Biosciences Inc. stock benefit from sector rotationLong Setup & Weekly Watchlist for Hot Stocks - DonanımHaber

Dec 19, 2025

Dec 18, 2025

What analyst consensus says on Jade Biosciences Inc. stock2025 Trade Ideas & Fast Entry Momentum Alerts - Улправда

Dec 18, 2025

Dec 17, 2025

JBIO Surges Over 75% In Just Two Months On Pipeline MomentumDid You Take The Bet? - RTTNews

Dec 17, 2025

Dec 16, 2025

Latham & Watkins Advises Jade Biosciences on US$45 Million Private Placement - Legal Desire Media and Insights

Dec 16, 2025

Jade Biosciences prices 3.21M shares at $14.00 in private placement - MSN

Dec 16, 2025

Dec 15, 2025

Jade Biosciences secures $45 million in private placement from BB Biotech - Investing.com Nigeria

Dec 15, 2025

Jade Biosciences secures $45 million in private placement from BB Biotech By Investing.com - Investing.com South Africa

Dec 15, 2025

Jade Biosciences Says to Raise $45 Million via Private Placement of 3.2 Million Shares - marketscreener.com

Dec 15, 2025

Jade Biosciences announces $45 million private placement - marketscreener.com

Dec 15, 2025

Jade Biosciences Announces $45 Million Private Placement - GlobeNewswire

Dec 15, 2025

Dec 14, 2025

Frazier Life Sciences Management L.P. Makes New $17.70 Million Investment in Jade Biosciences, Inc. $JBIO - MarketBeat

Dec 14, 2025

Dec 12, 2025

Jade Biosciences (NASDAQ:JBIO) Trading 7.4% HigherHere's What Happened - MarketBeat

Dec 12, 2025

Jade Biosciences, Inc. announced that it expects to receive $45.000004 million in funding - marketscreener.com

Dec 12, 2025

Dec 10, 2025

The growth track for Jade Biosciences Inc (JBIO) has changed recently - setenews.com

Dec 08, 2025

Dec 06, 2025

Jade Biosciences (NASDAQ:JBIO) Sees Large Volume IncreaseHere's What Happened - MarketBeat

Dec 06, 2025

Geode Capital Management LLC Purchases Shares of 676,431 Jade Biosciences, Inc. $JBIO - MarketBeat

Dec 06, 2025

Dec 04, 2025

Does Jade Biosciences, Inc. (JBIO) Have the Potential to Rally 65% as Wall Street Analysts Expect? - Zacks Investment Research

Dec 04, 2025

Dec 03, 2025

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Boston Scientific (BSX) - The Globe and Mail

Dec 03, 2025

Dec 01, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives $19.75 Average Price Target from Brokerages - Defense World

Dec 01, 2025

Nov 29, 2025

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 29, 2025

Nov 27, 2025